జర్నల్ ఆఫ్ ట్రామాటిక్ స్ట్రెస్ డిజార్డర్స్ & ట్రీట్‌మెంట్

Prevalence of PTSD Symptoms in Acute Myeloid Leukemia Patients

Jonas Mayor

Patients with intense myeloid leukemia (AML) getting serious chemotherapy face a dangerous disease, segregating hospitalization, and generous physical and mental indications. Nonetheless, information are restricted in regards to hazard variables of posttraumatic stress issue (PTSD) indications in this populace. The creators led an auxiliary examination of information from 160 patients with high-hazard AML who were taken on a steady consideration preliminary. The PTSD Checklist-Civilian Version was utilized to evaluate PTSD indications at multi month after AML finding. A generous extent of patients with AML report clinically critical PTSD side effects multi month in the wake of starting escalated chemotherapy. Patients’ benchmark QOL, adapting systems, and degree of QOL decay during hospitalization arise as significant danger factors for PTSD, highlighting the requirement for strong oncology intercessions to decrease the danger of PTSD in this populace. Patients with intense myeloid leukemia (AML) getting serious chemotherapy face a perilous ailment, separating hospitalization, and generous physical and mental side effects. Notwithstanding, information are restricted in regards to chance components of posttraumatic stress issue (PTSD) side effects in this populace.

నిరాకరణ: ఈ సారాంశం ఆర్టిఫిషియల్ ఇంటెలిజెన్స్ టూల్స్ ఉపయోగించి అనువదించబడింది మరియు ఇంకా సమీక్షించబడలేదు లేదా నిర్ధారించబడలేదు